119 related articles for article (PubMed ID: 32619673)
1. (-)-Kusunokinin inhibits breast cancer in N-nitrosomethylurea-induced mammary tumor rats.
Tedasen A; Dokduang S; Sukpondma Y; Lailerd N; Madla S; Sriwiriyajan S; Rattanaburee T; Tipmanee V; Graidist P
Eur J Pharmacol; 2020 Sep; 882():173311. PubMed ID: 32619673
[TBL] [Abstract][Full Text] [Related]
2. (-)-Kusunokinin and piperloguminine from Piper nigrum: An alternative option to treat breast cancer.
Sriwiriyajan S; Sukpondma Y; Srisawat T; Madla S; Graidist P
Biomed Pharmacother; 2017 Aug; 92():732-743. PubMed ID: 28586745
[TBL] [Abstract][Full Text] [Related]
3. Anticancer activity of synthetic (±)-kusunokinin and its derivative (±)-bursehernin on human cancer cell lines.
Rattanaburee T; Thongpanchang T; Wongma K; Tedasen A; Sukpondma Y; Graidist P
Biomed Pharmacother; 2019 Sep; 117():109115. PubMed ID: 31220743
[TBL] [Abstract][Full Text] [Related]
4. Anti-cancer effects of Piper nigrum via inducing multiple molecular signaling in vivo and in vitro.
Deng Y; Sriwiriyajan S; Tedasen A; Hiransai P; Graidist P
J Ethnopharmacol; 2016 Jul; 188():87-95. PubMed ID: 27155135
[TBL] [Abstract][Full Text] [Related]
5. Trans-(-)-Kusunokinin: A Potential Anticancer Lignan Compound against HER2 in Breast Cancer Cell Lines?
Rattanaburee T; Tanawattanasuntorn T; Thongpanchang T; Tipmanee V; Graidist P
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361688
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CSF1R and AKT by (±)-kusunokinin hinders breast cancer cell proliferation.
Rattanaburee T; Tipmanee V; Tedasen A; Thongpanchang T; Graidist P
Biomed Pharmacother; 2020 Sep; 129():110361. PubMed ID: 32535390
[TBL] [Abstract][Full Text] [Related]
7. Anticancer and Cancer Prevention Effects of Piperine-Free Piper nigrum Extract on N-nitrosomethylurea-Induced Mammary Tumorigenesis in Rats.
Sriwiriyajan S; Tedasen A; Lailerd N; Boonyaphiphat P; Nitiruangjarat A; Deng Y; Graidist P
Cancer Prev Res (Phila); 2016 Jan; 9(1):74-82. PubMed ID: 26511488
[TBL] [Abstract][Full Text] [Related]
8. Anticancer Activity of (±)-Kusunokinin Derivatives towards Cholangiocarcinoma Cells.
Rattanaburee T; Sermmai P; Tangthana-Umrung K; Thongpanchang T; Graidist P
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500383
[TBL] [Abstract][Full Text] [Related]
9. Dietary lariciresinol attenuates mammary tumor growth and reduces blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.
Saarinen NM; Wärri A; Dings RP; Airio M; Smeds AI; Mäkelä S
Int J Cancer; 2008 Sep; 123(5):1196-204. PubMed ID: 18528864
[TBL] [Abstract][Full Text] [Related]
10. Meso-dihydroguaiaretic acid induces apoptosis and inhibits cell migration via p38 activation and EGFR/Src/intergrin β3 downregulation in breast cancer cells.
Choi MS; Jeong HJ; Kang TH; Shin HM; Oh ST; Choi Y; Jeon S
Life Sci; 2015 Nov; 141():81-9. PubMed ID: 26382595
[TBL] [Abstract][Full Text] [Related]
11. Erufosine suppresses breast cancer in vitro and in vivo for its activity on PI3K, c-Raf and Akt proteins.
Dineva IK; Zaharieva MM; Konstantinov SM; Eibl H; Berger MR
J Cancer Res Clin Oncol; 2012 Nov; 138(11):1909-17. PubMed ID: 22752602
[TBL] [Abstract][Full Text] [Related]
12. Neem leaf extract inhibits mammary carcinogenesis by altering cell proliferation, apoptosis, and angiogenesis.
Arumugam A; Agullo P; Boopalan T; Nandy S; Lopez R; Gutierrez C; Narayan M; Rajkumar L
Cancer Biol Ther; 2014 Jan; 15(1):26-34. PubMed ID: 24146019
[TBL] [Abstract][Full Text] [Related]
13. The effect of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumours.
Purohit A; Hejaz HA; Walden L; MacCarthy-Morrogh L; Packham G; Potter BV; Reed MJ
Int J Cancer; 2000 Feb; 85(4):584-9. PubMed ID: 10699934
[TBL] [Abstract][Full Text] [Related]
14. Long chain n-3 polyunsaturated fatty acids increase the efficacy of docetaxel in mammary cancer cells by downregulating Akt and PKCε/δ-induced ERK pathways.
Chauvin L; Goupille C; Blanc C; Pinault M; Domingo I; Guimaraes C; Bougnoux P; Chevalier S; Mahéo K
Biochim Biophys Acta; 2016 Apr; 1861(4):380-90. PubMed ID: 26821209
[TBL] [Abstract][Full Text] [Related]
15. Tranilast inhibits cell proliferation and migration and promotes apoptosis in murine breast cancer.
Subramaniam V; Chakrabarti R; Prud'homme GJ; Jothy S
Anticancer Drugs; 2010 Apr; 21(4):351-61. PubMed ID: 20145538
[TBL] [Abstract][Full Text] [Related]
16. Effects of trans-(±)-kusunokinin on chemosensitive and chemoresistant ovarian cancer cells.
Mad-Adam N; Rattanaburee T; Tanawattanasuntorn T; Graidist P
Oncol Lett; 2022 Feb; 23(2):59. PubMed ID: 34992691
[TBL] [Abstract][Full Text] [Related]
17. Dual Inhibition of Key Proliferation Signaling Pathways in Triple-Negative Breast Cancer Cells by a Novel Derivative of Taiwanin A.
Kuo YH; Chiang EI; Chao CY; Rodriguez RL; Chou PY; Tsai SY; Pai MH; Tang FY
Mol Cancer Ther; 2017 Mar; 16(3):480-493. PubMed ID: 27956520
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo assessments of two novel hydrazide compounds against breast cancer as well as mammary tumor cells.
Mousavi E; Tavakolfar S; Almasirad A; Kooshafar Z; Dehghani S; Afsharinasab A; Amanzadeh A; Shafiee S; Salimi M
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1195-1203. PubMed ID: 28451832
[TBL] [Abstract][Full Text] [Related]
19. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer.
Chen X; Zhao M; Hao M; Sun X; Wang J; Mao Y; Zu L; Liu J; Shen Y; Wang J; Shen K
Mol Cancer Res; 2013 Oct; 11(10):1269-78. PubMed ID: 23814023
[TBL] [Abstract][Full Text] [Related]
20. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors.
Cohen LA; Marks PA; Rifkind RA; Amin S; Desai D; Pittman B; Richon VM
Anticancer Res; 2002; 22(3):1497-504. PubMed ID: 12168829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
